434 related articles for article (PubMed ID: 35069599)
1. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
Front Immunol; 2021; 12():811726. PubMed ID: 35069599
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
3. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
Simmerman E; Chung J; Lawson A; Kruse E
J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
[TBL] [Abstract][Full Text] [Related]
4. New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors.
Yun JH; Fang A; Khorshidi F; Habibollahi P; Kutsenko O; Etezadi V; Hunt S; Nezami N
Curr Oncol Rep; 2023 Nov; 25(11):1213-1226. PubMed ID: 37695398
[TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
6. [Irreversible electroporation: local tumor ablation with systemic immune effect].
Geboers B; Timmer FEF; van den Tol PM; de Gruijl TD; Scheffer HJ; Meijerink MR
Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854585
[TBL] [Abstract][Full Text] [Related]
7. Electric Pulse Responsive Magnetic Nanoclusters Loaded with Indoleamine 2,3-Dioxygenase Inhibitor for Synergistic Immuno-Ablation Cancer Therapy.
Yu B; Zhang W; Kwak K; Choi H; Kim DH
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54415-54425. PubMed ID: 33237729
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model.
Imran KM; Brock RM; Beitel-White N; Powar M; Orr K; Aycock KN; Alinezhadbalalami N; Salameh ZS; Eversole P; Tintera B; Markov Madanick J; Hendricks-Wenger A; Coutermarsh-Ott S; Davalos RV; Allen IC
Front Immunol; 2024; 15():1352821. PubMed ID: 38711517
[TBL] [Abstract][Full Text] [Related]
9. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
Shankara Narayanan JS; Hayashi T; Erdem S; McArdle S; Tiriac H; Ray P; Pu M; Mikulski Z; Miller A; Messer K; Carson D; Schoenberger S; White RR
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36634919
[TBL] [Abstract][Full Text] [Related]
12. Irreversible electroporation: Beyond the limits of tumor ablation.
Alonso-González R; Abadal Villayandre JM; Gálvez Gonzalez E; Álvarez Perez MJ; Méndez Alonso S; de Gregorio Ariza MA
Radiologia (Engl Ed); 2024; 66(1):47-56. PubMed ID: 38365354
[TBL] [Abstract][Full Text] [Related]
13. The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field.
Lv Y; Liu H; Feng Z; Zhang J; Chen G; Yao C
Ann Biomed Eng; 2022 Dec; 50(12):1964-1973. PubMed ID: 35852648
[TBL] [Abstract][Full Text] [Related]
14. [Irreversible electroporation: a new form of image-guided tumour ablation].
Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
[TBL] [Abstract][Full Text] [Related]
15. Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method.
Gajewska-Naryniecka A; Szwedowicz U; Łapińska Z; Rudno-Rudzińska J; Kielan W; Kulbacka J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901812
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Hepatic Lesions After non-Thermal Tumor Ablation by Irreversible Electroporation in a Pig Model.
Jeon SM; Davaa E; Jiang Y; Jenjob R; Truong NT; Shin KJ; Jeong S; Yang SG
Technol Cancer Res Treat; 2023; 22():15330338221147122. PubMed ID: 37861099
[TBL] [Abstract][Full Text] [Related]
17. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma.
Woeste MR; Shrestha R; Geller AE; Li S; Montoya-Durango D; Ding C; Hu X; Li H; Puckett A; Mitchell RA; Hayat T; Tan M; Li Y; McMasters KM; Martin RCG; Yan J
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072351
[TBL] [Abstract][Full Text] [Related]
18. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
19. High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity.
Ringel-Scaia VM; Beitel-White N; Lorenzo MF; Brock RM; Huie KE; Coutermarsh-Ott S; Eden K; McDaniel DK; Verbridge SS; Rossmeisl JH; Oestreich KJ; Davalos RV; Allen IC
EBioMedicine; 2019 Jun; 44():112-125. PubMed ID: 31130474
[TBL] [Abstract][Full Text] [Related]
20. Immunologic response to tumor ablation with irreversible electroporation.
Li X; Xu K; Li W; Qiu X; Ma B; Fan Q; Li Z
PLoS One; 2012; 7(11):e48749. PubMed ID: 23139816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
